临床儿科杂志 ›› 2021, Vol. 39 ›› Issue (5): 382-.doi: 10.3969/j.issn.1000-3606.2021.05.014

• 综合报道 • 上一篇    下一篇

HCN1 基因新生变异致Dravet 综合征1 例

余小华, 田茂强, 李娟, 郎长会, 束晓梅   

  1. 遵义医科大学附属医院儿科(贵州遵义 563000)
  • 发布日期:2021-05-07

Case report of a child with Dravet syndrome caused by a de novo heterozygous mutation in HCN1 gene mutation

n YU Xiaohua, TIAN Maoqiang, LI Juan, LANG Changhui, SU Xiaomei   

  1. Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou, China
  • Published:2021-05-07

摘要: 目的 探讨Dravet综合征临床及HCN1基因变异特征。方法 回顾分析1例Dravet综合征患儿的临床资料及 基因检测结果。结果 1岁11个月女性患儿,4月龄起病,表现为反复发热诱发的惊厥发作,发作时呈惊厥持续状态,发作 形式多样。基因检测发现HCN 1基因c. 1199 T>C错义变异,导致第400号亮氨酸变异为脯氨酸(p.Leu 400 Pro);其父母该 位点未见异常,为新生变异,尚未见报道。结论 明确HCN 1基因新生变异为致病基因,丰富了Dravet综合征的基因型。

关键词: Dravet综合征; 早期婴儿癫痫性脑病; 新生变异; HCN 1基因

Abstract: Objective To explore the clinical manifestations and HCN 1 gene mutation in Dravet syndrome. Methods The clinical data and gene test results of Dravet syndrome in a child were retrospectively analyzed. Results The proband was a one year and 11 months old female who had recurrent febrile seizure onset from 4 months old, she presented with status epilepticus and various seizure types. Gene sequencing identified a de novo heterozygous mutation of c.1199 T>C (p.L400 P) in the HCN 1 gene. Conclusion The novel mutation of HCN 1 gene was classified as pathogenic, which enriched the mutation spectrum of Dravet syndrome.

Key words: Dravet syndrome; early infantile epileptic encephalopathy; de novo mutation; HCN 1 gene